Eddie Williams

Insider

First SEC filing: Jan. 2, 2018 · Latest: Jan. 2, 2018

On this page

Insider at Companies where this person is a reporting insider.
Insider transactions Every share this person bought or sold, from Form 4 filings.
Derivatives Options and other derivative holdings reported by this person.
Initial holdings The stakes this person held when they first started reporting.

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 27 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

27 other filings hidden

Date	Ticker	Code	Shares	Price	Value	Owned after	Δ own	A/D	vs now
June 18, 2025	BCAB	A	23,500	—	—	60,200 Direct	+64.03%	Acquired	(price as of 2026-08-20)
June 13, 2024	BCAB	A	16,500	—	—	36,700 Direct	+81.68%	Acquired	(price as of 2026-08-20)
Dec. 31, 2023	BCAB	A	4,827	—	—	20,200 Direct	+31.40%	Acquired	(price as of 2026-08-20)
Sept. 30, 2023	BCAB	A	6,985	—	—	15,373 Direct	+83.27%	Acquired	(price as of 2026-08-20)
June 30, 2023	BCAB	A	3,958	—	—	8,388 Direct	+89.35%	Acquired	(price as of 2026-08-20)
June 14, 2023	BCAB	A	50,000	—	—	50,000 Direct	—	Acquired	(price as of 2026-08-20)
March 31, 2023	BCAB	A	4,430	—	—	4,430 Direct	—	Acquired	(price as of 2026-08-20)
June 16, 2022	BCAB	A	20,000	—	—	20,000 Direct	—	Acquired	(price as of 2026-08-20)
Jan. 7, 2022	GYRE	A	12,308	—	—	34,804 Direct	+54.71%	Acquired	(price as of 2026-08-20)
Dec. 16, 2021	BCAB	A	25,000	—	—	25,000 Direct	—	Acquired	(price as of 2026-08-20)
Oct. 1, 2021	GYRE	A	2,980	—	—	22,496 Direct	+15.27%	Acquired	(price as of 2026-08-20)
July 1, 2021	GYRE	A	1,414	—	—	19,516 Direct	+7.81%	Acquired	(price as of 2026-08-20)
June 9, 2021	GYRE	A	14,000	—	—	14,000 Direct	—	Acquired	(price as of 2026-08-20)
April 1, 2021	GYRE	A	1,215	—	—	18,102 Direct	+7.19%	Acquired	(price as of 2026-08-20)
Jan. 5, 2021	GYRE	A	940	—	—	16,887 Direct	+5.89%	Acquired	(price as of 2026-08-20)
Oct. 1, 2020	GYRE	A	1,380	—	—	15,947 Direct	+9.47%	Acquired	(price as of 2026-08-20)
July 1, 2020	GYRE	A	1,011	—	—	14,567 Direct	+7.46%	Acquired	(price as of 2026-08-20)
June 11, 2020	GYRE	A	5,000	—	—	5,000 Direct	—	Acquired	(price as of 2026-08-20)
April 1, 2020	GYRE	A	2,717	—	—	13,556 Direct	+25.07%	Acquired	(price as of 2026-08-20)
March 4, 2020	GYRE	P	2,000	$5.78	$11,560	10,839 Direct	+22.63%	Acquired	-91.9% (price as of 2026-08-20)
Jan. 2, 2020	GYRE	A	1,743	—	—	8,839 Direct	+24.56%	Acquired	(price as of 2026-08-20)
Oct. 1, 2019	GYRE	A	2,418	—	—	7,096 Direct	+51.69%	Acquired	(price as of 2026-08-20)
July 1, 2019	GYRE	A	1,642	—	—	4,678 Direct	+54.08%	Acquired	(price as of 2026-08-20)
June 13, 2019	GYRE	A	5,000	—	—	5,000 Direct	—	Acquired	(price as of 2026-08-20)
April 1, 2019	GYRE	A	1,364	—	—	3,036 Direct	+81.58%	Acquired	(price as of 2026-08-20)
Dec. 31, 2018	GYRE	A	1,544	—	—	1,672 Direct	+1206.25%	Acquired	(price as of 2026-08-20)
June 13, 2018	GYRE	A	5,000	—	—	5,000 Direct	—	Acquired	(price as of 2026-08-20)
Jan. 2, 2018	GYRE	A	10,000	—	—	10,000 Direct	—	Acquired	(price as of 2026-08-20)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date	Ticker	Security	Underlying	Exercise price	Expiration	Shares	A/D
June 14, 2023	BCAB	Stock Option (Right to Buy)	Common Stock (50,000)	$3.55	June 14, 2033	50,000	Acquired
June 16, 2022	BCAB	Stock Option (right to buy)	Common Stock (20,000)	$2.48	June 16, 2032	20,000	Acquired
Dec. 16, 2021	BCAB	Stock Option (Right to Buy)	Common Stock (25,000)	$19.57	Dec. 16, 2031	25,000	Acquired
June 9, 2021	GYRE	Stock Option (Right to Buy)	Common Stock (14,000)	$4.55	June 9, 2031	14,000	Acquired
June 11, 2020	GYRE	Stock Option (Right to Buy)	Common Stock (5,000)	$7.18	June 11, 2030	5,000	Acquired
June 13, 2019	GYRE	Stock Option (Right to Buy)	Common Stock (5,000)	$7.46	June 13, 2029	5,000	Acquired
June 13, 2018	GYRE	Stock Option (Right to Buy)	Common Stock (5,000)	$24.94	June 13, 2028	5,000	Acquired
Jan. 2, 2018	GYRE	Stock Option (Right to Buy)	Common Stock (10,000)	$14.37	Jan. 2, 2028	10,000	Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 1 holding

Securities held when first becoming an insider, per SEC Form 3.

Date	Ticker	Security	Shares	Ownership
Jan. 2, 2018	GYRE	Common Stock	128	Direct